Ligand Pharmaceuticals stock hits 52-week high at $183.98
PositiveFinancial Markets

Ligand Pharmaceuticals has reached a significant milestone as its stock hits a 52-week high of $183.98. This achievement reflects the company's strong performance and investor confidence, which is crucial in the competitive pharmaceutical industry. Such highs can attract more investors and potentially lead to further growth and innovation within the company.
— Curated by the World Pulse Now AI Editorial System